George Van Buren
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
The microenvironment that surrounds pancreatic ductal adenocarcinoma (PDAC) is profoundly desmoplastic and immunosuppressive. Understanding triggers of immunosuppression during the process of pancreatic tumorigenesis would aid in establishing targets for effective prevention and therapy. Here, we interrogated differential molecular mechanisms dependent on cell of origin and subtype that promote immunosuppression during PDAC initiation and in established tumors. Transcriptomic analysis of cell-of-origin–dependent epithelial gene signatures revealed that Nt5e/CD73, a cell-surface enzyme required for extracellular adenosine generation, is one of the top 10% of genes overexpressed in murine tumors arising from the ductal pancreatic epithelium as opposed to those rising from acinar cells. These findings were confirmed by IHC and high-performance liquid chromatography. Analysis in human PDAC subtypes indicated that high Nt5e in murine ductal PDAC models overlaps with high NT5E in human PDAC squamous and basal subtypes, considered to have the highest immunosuppression and worst prognosis. Multiplex immunofluorescent analysis showed that activated CD8 + T cells in the PDAC tumor microenvironment express high levels of CD73, indicating an opportunity for immunotherapeutic targeting. Delivery of CD73 small-molecule inhibitors through various delivery routes reduced tumor development and growth in genetically engineered and syngeneic mouse models. In addition, the adenosine receptor Adora2b was a determinant of adenosine-mediated immunosuppression in PDAC. These findings highlight a molecular trigger of the immunosuppressive PDAC microenvironment elevated in the ductal cell of origin, linking biology with subtype classification, critical components for PDAC immunoprevention and personalized approaches for immunotherapeutic intervention. Significance: Ductal-derived pancreatic tumors have elevated epithelial and CD8 + GZM + T-cell CD73 expression that confers sensitivity to small-molecule inhibition of CD73 or Adora2b to promote CD8 + T-cell–mediated tumor regression. See related commentary by DelGiorno, p. 977
Year:
2025
Year:
2023
Collaborators (12)
Dafna Bar-Sagi
NYU School of Medicine
Kyle Poulsen
Assistant Professor
Michigan State University
Holger Eltzschig
Professor and Chairman
McGovern Medical School at UTHealth
Erika Yanil Faraoni
The University of Texas MD Anderson Cancer Center
Nirav Thosani
Division Director/Professor
The University of Texas Health Science Center at Houston
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Tingting Mills
Assistant Professor
The University of Texas Health Science Center at Houston
Zhongming Zhao
Professor and Center Director
The University of Texas Health Science Center at Houston
yulin dai
The University of Texas Health Science Center at Houston
curtis wray
Professor
The University of Texas Health Science Center at Houston
Jennifer Bailey-Lundberg
Tenured Associate Professor
The University of Texas Health Science Center at Houston
Powel Brown
Professor and Chairman
The University of Texas MD Anderson Cancer Center
Make your next move.
Prepare your application
Review drafts before you send them.